Clinical Trial Update: Neutralizing Interferon Type 1 in Hidradenitis Suppurativa [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating a therapy that neutralizes type 1 interferon in hidradenitis suppurativa. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Hidradenitis Suppurativa (HS) | Phase 1 | Status: NOT_YET_RECRUITING